Tilray | TRLY - Assets

Stock Price
9.44
Daily Change
-0.04 -0.42%
Monthly
-7.99%
Yearly
926.09%
Q1 Forecast
9.24

Tilray reported $2.07B in Assets for its fiscal quarter ending in March of 2025.





Assets Change Date
Acasti Pharma USD 66.58M 3.22M Sep/2025
Akebia Therapeutics USD 376.56M 12.41M Dec/2025
Alaunos Therapeutics USD 3.72M 1.01M Sep/2025
Aurora Cannabis CAD 756.86M 80.98M Sep/2025
Avita Medical AUD 56.39M 1.74M Dec/2025
Canopy Growth CAD 1.07B 165.17M Sep/2025
Cronos Group USD 1.2B 18.73M Dec/2025
Dianthus Therapeutics USD 530.92M 46.52M Dec/2025
Divis Laboratories Ltd INR 181.51B 12.19B Sep/2025
Ionis Pharmaceuticals USD 3.52B 490.91M Dec/2025
IQVIA Holdings USD 29.94B 1.22B Dec/2025
Knight Therapeutics CAD 1.05B 10.63M Sep/2025
Moderna USD 12.34B 203M Dec/2025
Organigram Holdings CAD 562.21M 2.4M Sep/2025
Organon & Co USD 13.55B 52M Sep/2025
Revvity USD 12.17B 29.46M Dec/2025
Tectonic Therapeutic USD 277M 18.31M Sep/2025
Tilray USD 2.07B 1.33B Mar/2025
Viatris USD 37.19B 727.3M Dec/2025
Xeris Pharmaceuticals USD 370.19M 35.5M Sep/2025